ZYMVOL funding news – Spanish Biotech Startup ZYMVOL Secures €3 Million in Seed Funding

The new funding will help ZYMVOL grow in several important areas:

• Improve its lab at the Barcelona Science Park to speed up enzyme discovery.
• Develop its technology to make enzyme predictions more accurate and efficient.
• Grow its sales and marketing team to attract new customers and reach more industries.
• Launch its first custom enzyme kits, making enzyme use easier for more people.

Enzymes, or biocatalysts, are proteins found in living organisms that speed up chemical reactions. They have been used in industries for years to improve products like detergents and lactose-free milk, and to replace harmful traditional catalysts.

For enzymes to work in industrial settings, they need to be specially designed to handle tough conditions. Traditional methods of designing enzymes take a long time and can be expensive.

Read also - Pixel Photonics funding news – Munster-based DeepTech Startup Pixel Photonics Secures €1 Million in Funding

ZYMVOL, founded in 2017 by Emanuele Monza, Victor Gil, and Maria Fatima Lucas in Barcelona, aims to make better, more sustainable enzymes available to industries. The company partners with research teams from major companies to improve production processes, promote innovation, and reduce environmental impact by creating custom enzyme solutions.

ZYMVOL’s new method changes the way enzymes are developed. The company uses computer-simulated experiments that closely match real-world conditions with over 90% accuracy.

This technology helps save time and money by finding the best enzyme candidates before they go to the lab. It also allows the discovery of new enzymes for specific reactions, opening up new possibilities for industries looking for enzymatic solutions.

ZYMVOL has completed over 100 projects in different fields, mainly in pharmaceuticals and chemicals. The company works with big clients like Axplora, Medichem, and Sanofi, offering enzyme solutions that improve manufacturing efficiency and sustainability.

With a team of over 20 experts and offices in Barcelona and Boston, the company is ready to grow further. Its ability to digitally simulate millions of experiments gives it an advantage in the fast-growing enzyme market.

Enzymes are crucial for sustainable industrial change. They work under mild conditions, reducing energy use and avoiding harmful chemicals, making them key to a greener economy. ZYMVOL’s efficient and cost-effective enzyme engineering is helping lead the way toward cleaner, more sustainable manufacturing processes.

Maria Fátima Lucas, CEO of ZYMVOL said, “Enzymes are tiny chemical factories that are responsible for all transformations in Nature. Zymvol is harnessing their power to deliver clean, sustainable chemical processes to companies striving to improve their products and operations—paving the way for a better world,".

Sofia Santos, Partner at Faber Ventures said, “Enzymes power innovation across industries, from sustainable manufacturing to pharmaceutical breakthroughs. However, biocatalysis presents significant challenges —enzyme discovery and engineering remain complex, costly, and time-consuming. Zymvol’s advanced computational solutions go beyond improving efficiency they strengthen industrial resilience, drive sustainable innovation, and shape the future of global production,”.

Sébastien Lefebvre, Partner at Elaia said, “Over the past few years, Zymvol has revolutionised the way enzymes are discovered and engineered. Zymvol now outperforms alternative solutions across all key factors, including speed of development, specificity and efficiency. We are pleased to continue supporting the company as it expands its portfolio of enzymes and scales operations internationally,”.

About Zymvol

Zymvol is a biotech company that creates custom-made enzymes to meet their clients' specific needs. They use advanced technology and expert science to make biocatalysis accessible to everyone.

Zymvol is a reliable partner, helping customers at every step of their process from defining and planning projects to developing and delivering personalized enzymes.